View in EDS

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.

Saved in:
Bibliographic Details
Title: Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.
Authors: Alvi, Muhammad A1, Loughrey, Maurice B, Dunne, Philip1, McQuaid, Stephen1, Turkington, Richard2, Fuchs, Marc-Aurel1, McGready, Claire1, Bingham, Victoria1, Pang, Brendan3, Moore, Wendy1, Maxwell, Perry1, Lawler, Mark2, James, Jacqueline A1, Murray, Graeme I4, Wilson, Richard H2, Salto-Tellez, Manuel
Source: British Journal of Cancer. 7/11/2017, Vol. 117 Issue 2, p203-209. 7p. 1 Diagram, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/bjc.2017.168